Circulating Inflammation Markers and Risk of Gastric and Esophageal Cancers: A Case–Cohort Study Within the Japan Public Health Center–Based Prospective Study
M. Constanza Camargo(National Institutes of Health), Charles S. Rabkin(National Cancer Institute), Shoichiro Tsugane(International University of Health and Welfare), Taiki Yamaji, Allan Hildesheim(Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud), Troy J. Kemp(Leidos (United States)), Minkyo Song(National Institutes of Health), Norie Sawada(National Cancer Center), Hadrien Charvat(Juntendo University), Taichi Shimazu, Ligia A. Pinto(Leidos (United States)), Ruth M. Pfeiffer(National Institutes of Health)
Cited by 11
Related Papers
Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer
|Nature Medicine|2019|1.5k
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
|Nature Genetics|2013|922
Metabolic gene polymorphism frequencies in control populations.
|PubMed|2001|847
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas
|Cancer Cell|2018|718
Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study
|The Lancet Oncology|2021|684